Glucolipid Metabolic Disorders is an international, peer-reviewed, multi-disciplinary journal for physicians, clinicians, and scientists with an interest in glucose and lipid metabolic disorders in pathological processes, as well as the therapeutics targeting these disorders to treat human diseases.
Glucolipid Metabolic Disorders publishes ...read more
Glucolipid Metabolic Disorders is an international, peer-reviewed, multi-disciplinary journal for physicians, clinicians, and scientists with an interest in glucose and lipid metabolic disorders in pathological processes, as well as the therapeutics targeting these disorders to treat human diseases.
Glucolipid Metabolic Disorders publishes original research articles, guidelines, reviews, and commentaries on a broad range of topics. The journal is particularly interested in manuscripts that address important advances in glucolipid metabolomics and the clinical application of targeting glucose and lipid metabolism. Areas of interest cover, but are not limited to:
• Clinical applications of targeting glucose and lipid metabolism to improve patient care and outcomes
• Clinical trials illustrating the use of targeting glucose and lipid metabolism
• Conceptual characterization of glucolipid metabolic disorders
• Mechanisms of glucolipid metabolic disorders in diseases
• Metabolomics of glucose and lipids
• Methodologies & preclinical and clinical applications of glucolipid metabolomics
• Novel techniques & approaches for the advancement of glucolipid metabolomics
• Translational research in glucolipid metabolomics
Glucolipid Metabolic Disorders is an international, peer-reviewed journal on all aspects of glucolipid metabolomics, published continuously (print & online) by Bentham Science Publishers.
